Fansidar smpc

The MEB publishes national assessment reports containing a brief discussion of data from the marketing authorisation dossier. The report indicates the data famciclovir. FAMILIAL ADENOMATOUS POLYPOSIS famotidine famotidine, calcium carbonate, and magnesium hydroxide. Famvir Fansidar Farbital Fareston

A new document is an SPC or PIL which has never been published on the eMC website before SPC, or SmPC, stands for Summary of Product Characteristics

Consumer information about the medication SULFADOXINEPYRIMETHAMINE - ORAL (Fansidar), includes side effects, drug interactions, recommended May 6, 2014 Treatment R: Reference 3 x Fansidar 50025 mg tablet to the SPC ( WHOPAR part 4) for data on clinical safety. 5. defined in the SmPC Fansidar official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more

CBG-MEB - Public assessment reports

May 27, 2009 Information on FANSIDAR (Sulfadoxine, pyrimethamine) including summary of product characteristics (SPC) with access to related guidelines, Oct 10, 2008 Learn about the prescription medication Fansidar (Sulfadoxine and Pyrimethamine), drug uses, dosage, side effects, drug interactions,

pyrimethamine (in Fansidar and Maloprim ). Cytotoxics: The antifolate effect of methotrexate is increased when trimethoprim is used concurrently - avoid May 4, 2014 WHOPAR, with part 4 Summary of Product Characteristics (SmPC) for Fansidar USPI (2005) http:www.drugs.comprofansidar.html